Nuclear Medicine Therapeutics to Drive Global Nuclear Medicine Market

2026-07-07 11:56:40 Health and Fitness

779

According to a new research report by RNCOS entitled, ?Global Nuclear Medicine Outlook 2020?, the Nuclear Medicine Therapeutics is the most promising segment of the Global Nuclear medicine market. Nuclear Medicine Therapy involves the usage of therapeutic radiopharmaceuticals, particularly for the treatment of different types of cancers, including thyroid cancer, liver cancer, bone metastases, prostate cancer, breast cancer, cervix cancer, skin cancer and non-Hodgkin's lymphoma.

The increasing popularity of Nuclear Medicine Therapy is mainly due to its specificity, safety and effectiveness. Currently, the most commonly used radiopharmaceuticals for Nuclear Medicine based therapy include Beta-emitters such as Iodine-131, Yttrium-90, Phosphorous-32, Samarium-153 and Strontium-89, and short-range Brachytherapy radiopharmaceuticals such as Cesium-131, Iodine-125 and Palladium-103.

Growing demand for new therapeutic radiopharmaceuticals in the treatment of endocrinological and neurological tumors has further transformed Nuclear Medicine Therapeutics into a lucrative business opportunity. The Nuclear Medicine Therapeutics market is expected to witness significant growth in the future with the launch of new therapeutic radiopharmaceuticals. The emerging field of Targeted Alpha Therapy, where alpha emitting radiopharmaceuticals are conjugated to a carrier like an antibody, is anticipated to transform the treatment regimes for different types of tumors.

Moreover, with the advent of new therapeutic radiopharmaceuticals and the introduction of specific therapies, Nuclear Medicine Therapeutics holds great promise to emerge as the more focused and personalized treatment strategy.

Considering the advantages of high potency and specificity associated with the Nuclear Medicine Therapy, considerable research is underway to find reliable and cost effective sources of various therapeutic radiopharmaceuticals. The segment is likely to attract huge investments from the industry players for the research and development of new technologies, thus fuelling the future growth in the Global Nuclear Medicine market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM797.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

ABOUT RNCOS

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.